Benzinga | Jul 30, 2021 07:10AM EDT

Lexicon Pharmaceuticals Q2 EPS $(0.13) Beats $(0.16) Estimate, Sales $200.00K Beat $10.00K Estimate

Lexicon Pharmaceuticals (NASDAQ:LXRX) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.16) by 18.75 percent. This is a 80 percent increase over losses of $(0.65) per share from the same period last year. The company reported quarterly sales of $200.00 thousand which beat the analyst consensus estimate of $10.00 thousand by 1.90K percent. This is a 97.82 percent decrease over sales of $9.16 million the same period last year.